Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EU Committee to reconsider zinc oxide decision
Piglet
The NPA estimates that between 70 - 90 per cent of piglet diets contain zinc oxide at therapeutic levels.

Announcement welcomed by pig producers

The European Committee is to reconsider its recommendation to withdraw veterinary medicines containing zinc oxide, following a number of appeals from across the EU.

In December, the EU Committee for Medicinal Products for Veterinary Use (CVMP) called for a ban on zinc oxide in response to concerns over its risk to the environment.

The committee claimed that the treatment benefits of zinc oxide for the prevention of diarrhoea in pigs did not outweigh the environmental risk associated with their use.

In light of recent fightback, the CVMP has decided to reevaluate its opinion, suggesting that this will be reached by the beginning of April. Once the final opinion is published, the EU Commission will begin the formal decision-making process.

Welcoming the news, National Pig Association (NPA) chief executive Zoe Davis said: “We will continue to argue that the huge benefits of using zinc oxide in piglet feed far outweigh any environmental costs, which can be mitigated by either adopting a regional approach or reducing inclusion levels."

Last week, the National Pig Association (NPA) issued a briefing to the VMD - which represents the UK on the CVMP - outlining the impact of zinc oxide ban on the pig industry.

The NPA estimates that between 70 - 90 per cent of piglet diets contain zinc oxide at therapeutic levels, meaning a ban would cause ‘widespread deterioration in pig health and welfare’.

"Losing medicinal zinc oxide would seriously hamper the ability of the pig sector to further reduce its use of antibiotics. An increased use of antibiotics above their current levels may, in turn, result in further development of bacterial resistance, jeopardising the health of both animals and humans," the NPA briefing said.

The briefing also addressed concerns about environmental pollution from the use of zinc oxide. It pointed out that the application rate of zinc oxide onto UK soils from pig slurry is estimated to be well below the limit applied by Defra and the Environment Agency.

It concluded: "NPA is strongly against any ban on the therapeutic use of zinc oxide and instead would favour either a regionalised application of policy or an approach that reduces the inclusion levels of zinc oxide to minimise environmental risk without jeopardising pig health and welfare."

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.